Results 231 to 240 of about 119,198,728 (316)
Bringing attention to the moral dilemmas raised by xenotransplantation and the continuous creation of standardized frameworks for donor technology and biosafety risk management, with a focus on striking a balance between patient safety, medical innovation, and ethical obligation.
Sankhajyoti Saha +2 more
wiley +1 more source
A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B. [PDF]
Asselah T +10 more
europepmc +1 more source
The T cell‐inflamed gene expression profile (GEP) provides a biomarker for immunotherapy response across various cancers. We established a CT‐based radiomics model to predict the T cell‐inflamed GEP and immunotherapy response in hepatocellular carcinoma (HCC).
Mimi Tang +11 more
wiley +1 more source
Plant-Based Virus-like Particle (VLP) Vaccines Against Influenza and Hepatitis Viruses. [PDF]
Shahgolzari M +7 more
europepmc +1 more source
ABSTRACT Background Immunotherapy is increasingly used for head and neck cutaneous squamous cell carcinoma (cSCC) with perineural spread (PNS), though outcomes remain poorly defined. Methods A systematic review was conducted according to PRISMA and MOOSE guidelines.
Jai Paris +4 more
wiley +1 more source
Environmental determinants of hepatitis E seroprevalence in internally displaced populations: a geospatial study from Sudan. [PDF]
Osman HA +6 more
europepmc +1 more source
The hidden burden of viral hepatitis B and C in healthcare settings: a cross-sectional study of seroprevalence, predictors, and occult infection. [PDF]
Kostinov M +17 more
europepmc +1 more source

